Logo image of DSGX

DESCARTES SYSTEMS GRP/THE (DSGX) Stock Fundamental Analysis

USA - NASDAQ:DSGX - CA2499061083 - Common Stock

103.35 USD
+1.5 (+1.47%)
Last: 9/22/2025, 8:13:30 PM
103.35 USD
0 (0%)
After Hours: 9/22/2025, 8:13:30 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to DSGX. DSGX was compared to 279 industry peers in the Software industry. DSGX gets an excellent profitability rating and is at the same time showing great financial health properties. DSGX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes DSGX very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

DSGX had positive earnings in the past year.
DSGX had a positive operating cash flow in the past year.
In the past 5 years DSGX has always been profitable.
DSGX had a positive operating cash flow in each of the past 5 years.
DSGX Yearly Net Income VS EBIT VS OCF VS FCFDSGX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

1.2 Ratios

DSGX's Return On Assets of 8.44% is amongst the best of the industry. DSGX outperforms 83.51% of its industry peers.
The Return On Equity of DSGX (9.88%) is better than 77.06% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.18%, DSGX belongs to the top of the industry, outperforming 82.08% of the companies in the same industry.
DSGX had an Average Return On Invested Capital over the past 3 years of 8.86%. This is below the industry average of 11.86%.
The 3 year average ROIC (8.86%) for DSGX is below the current ROIC(9.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.44%
ROE 9.88%
ROIC 9.18%
ROA(3y)8.11%
ROA(5y)7.3%
ROE(3y)9.67%
ROE(5y)8.67%
ROIC(3y)8.86%
ROIC(5y)7.93%
DSGX Yearly ROA, ROE, ROICDSGX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

The Profit Margin of DSGX (21.64%) is better than 87.10% of its industry peers.
DSGX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 27.33%, DSGX belongs to the top of the industry, outperforming 91.04% of the companies in the same industry.
In the last couple of years the Operating Margin of DSGX has grown nicely.
The Gross Margin of DSGX (76.06%) is better than 70.97% of its industry peers.
DSGX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.33%
PM (TTM) 21.64%
GM 76.06%
OM growth 3Y3.87%
OM growth 5Y11.08%
PM growth 3Y2.7%
PM growth 5Y14.15%
GM growth 3Y-0.17%
GM growth 5Y0.52%
DSGX Yearly Profit, Operating, Gross MarginsDSGX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

8

2. Health

2.1 Basic Checks

DSGX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DSGX has been increased compared to 1 year ago.
The number of shares outstanding for DSGX has been increased compared to 5 years ago.
There is no outstanding debt for DSGX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DSGX Yearly Shares OutstandingDSGX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
DSGX Yearly Total Debt VS Total AssetsDSGX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

DSGX has an Altman-Z score of 21.69. This indicates that DSGX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of DSGX (21.69) is better than 93.55% of its industry peers.
DSGX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 21.69
ROIC/WACC0.86
WACC10.63%
DSGX Yearly LT Debt VS Equity VS FCFDSGX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

DSGX has a Current Ratio of 1.70. This is a normal value and indicates that DSGX is financially healthy and should not expect problems in meeting its short term obligations.
DSGX's Current ratio of 1.70 is in line compared to the rest of the industry. DSGX outperforms 53.76% of its industry peers.
A Quick Ratio of 1.70 indicates that DSGX should not have too much problems paying its short term obligations.
DSGX has a Quick ratio (1.70) which is in line with its industry peers.
DSGX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.7
DSGX Yearly Current Assets VS Current LiabilitesDSGX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

7

3. Growth

3.1 Past

DSGX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.19%, which is quite good.
Measured over the past years, DSGX shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.86% on average per year.
DSGX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.68%.
The Revenue has been growing by 14.85% on average over the past years. This is quite good.
EPS 1Y (TTM)14.19%
EPS 3Y18.17%
EPS 5Y30.86%
EPS Q2Q%7.5%
Revenue 1Y (TTM)12.68%
Revenue growth 3Y15.3%
Revenue growth 5Y14.85%
Sales Q2Q%10.05%

3.2 Future

DSGX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.86% yearly.
Based on estimates for the next years, DSGX will show a quite strong growth in Revenue. The Revenue will grow by 10.56% on average per year.
EPS Next Y13.83%
EPS Next 2Y29.89%
EPS Next 3Y23.99%
EPS Next 5Y21.86%
Revenue Next Year10.19%
Revenue Next 2Y11.81%
Revenue Next 3Y10.16%
Revenue Next 5Y10.56%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DSGX Yearly Revenue VS EstimatesDSGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B
DSGX Yearly EPS VS EstimatesDSGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 61.15, which means the current valuation is very expensive for DSGX.
DSGX's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.41, DSGX is valued quite expensively.
The Price/Forward Earnings ratio is 37.13, which means the current valuation is very expensive for DSGX.
DSGX's Price/Forward Earnings is on the same level as the industry average.
DSGX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.87.
Industry RankSector Rank
PE 61.15
Fwd PE 37.13
DSGX Price Earnings VS Forward Price EarningsDSGX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

DSGX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DSGX is cheaper than 73.84% of the companies in the same industry.
66.67% of the companies in the same industry are more expensive than DSGX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 38.39
EV/EBITDA 31.58
DSGX Per share dataDSGX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DSGX does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of DSGX may justify a higher PE ratio.
A more expensive valuation may be justified as DSGX's earnings are expected to grow with 23.99% in the coming years.
PEG (NY)4.42
PEG (5Y)1.98
EPS Next 2Y29.89%
EPS Next 3Y23.99%

0

5. Dividend

5.1 Amount

DSGX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DESCARTES SYSTEMS GRP/THE

NASDAQ:DSGX (9/22/2025, 8:13:30 PM)

After market: 103.35 0 (0%)

103.35

+1.5 (+1.47%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-03 2025-09-03/amc
Earnings (Next)12-01 2025-12-01/amc
Inst Owners86.14%
Inst Owner Change-11.1%
Ins Owners0.26%
Ins Owner ChangeN/A
Market Cap8.88B
Analysts77.78
Price Target99.59 (-3.64%)
Short Float %0.93%
Short Ratio1.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.34%
Min EPS beat(2)-6.83%
Max EPS beat(2)-1.85%
EPS beat(4)2
Avg EPS beat(4)-1.34%
Min EPS beat(4)-6.83%
Max EPS beat(4)2.86%
EPS beat(8)4
Avg EPS beat(8)-1.75%
EPS beat(12)7
Avg EPS beat(12)0.74%
EPS beat(16)9
Avg EPS beat(16)0.6%
Revenue beat(2)1
Avg Revenue beat(2)-0.24%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)1.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.27%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)2.1%
Revenue beat(8)4
Avg Revenue beat(8)-0.16%
Revenue beat(12)7
Avg Revenue beat(12)-0.19%
Revenue beat(16)11
Avg Revenue beat(16)0.38%
PT rev (1m)-2.06%
PT rev (3m)-0.89%
EPS NQ rev (1m)-4.52%
EPS NQ rev (3m)-9.78%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.09%
Revenue NQ rev (1m)1.98%
Revenue NQ rev (3m)-1.59%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 61.15
Fwd PE 37.13
P/S 12.97
P/FCF 38.39
P/OCF 37.34
P/B 5.92
P/tB 56.44
EV/EBITDA 31.58
EPS(TTM)1.69
EY1.64%
EPS(NY)2.78
Fwd EY2.69%
FCF(TTM)2.69
FCFY2.6%
OCF(TTM)2.77
OCFY2.68%
SpS7.97
BVpS17.45
TBVpS1.83
PEG (NY)4.42
PEG (5Y)1.98
Profitability
Industry RankSector Rank
ROA 8.44%
ROE 9.88%
ROCE 12.12%
ROIC 9.18%
ROICexc 10.87%
ROICexgc N/A
OM 27.33%
PM (TTM) 21.64%
GM 76.06%
FCFM 33.78%
ROA(3y)8.11%
ROA(5y)7.3%
ROE(3y)9.67%
ROE(5y)8.67%
ROIC(3y)8.86%
ROIC(5y)7.93%
ROICexc(3y)11.36%
ROICexc(5y)9.99%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.7%
ROCE(5y)10.48%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y6.45%
ROICexc growth 5Y18.03%
OM growth 3Y3.87%
OM growth 5Y11.08%
PM growth 3Y2.7%
PM growth 5Y14.15%
GM growth 3Y-0.17%
GM growth 5Y0.52%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 7.9%
Cap/Sales 0.95%
Interest Coverage 250
Cash Conversion 88.24%
Profit Quality 156.09%
Current Ratio 1.7
Quick Ratio 1.7
Altman-Z 21.69
F-Score7
WACC10.63%
ROIC/WACC0.86
Cap/Depr(3y)8.9%
Cap/Depr(5y)8.08%
Cap/Sales(3y)1.09%
Cap/Sales(5y)1.1%
Profit Quality(3y)168.32%
Profit Quality(5y)189.61%
High Growth Momentum
Growth
EPS 1Y (TTM)14.19%
EPS 3Y18.17%
EPS 5Y30.86%
EPS Q2Q%7.5%
EPS Next Y13.83%
EPS Next 2Y29.89%
EPS Next 3Y23.99%
EPS Next 5Y21.86%
Revenue 1Y (TTM)12.68%
Revenue growth 3Y15.3%
Revenue growth 5Y14.85%
Sales Q2Q%10.05%
Revenue Next Year10.19%
Revenue Next 2Y11.81%
Revenue Next 3Y10.16%
Revenue Next 5Y10.56%
EBIT growth 1Y21.74%
EBIT growth 3Y19.76%
EBIT growth 5Y27.58%
EBIT Next Year72.43%
EBIT Next 3Y29.63%
EBIT Next 5Y23.13%
FCF growth 1Y17.77%
FCF growth 3Y7.45%
FCF growth 5Y16.41%
OCF growth 1Y17.48%
OCF growth 3Y7.57%
OCF growth 5Y16.02%